Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Policy & Legislation › CDC Mandates Use of IGRAs for Immigration Tuberculosis Screening

CDC Mandates Use of IGRAs for Immigration Tuberculosis Screening

Feb 21, 2018
|
staff reporter

NEW YORK (360Dx) – The US Centers for Disease Control and Prevention has mandated that all US civil surgeons screening immigrants for latent tuberculosis must use an interferon-gamma release assay (IGRA) instead of the decades-old tuberculin skin test (TST).

The CDC is currently revising tuberculosis screening guidelines, referred to as technical instructions, which it provides to the US Department of State and US Citizenship and Immigration Services.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Apr
16
Featured Webinar

The Post-Vaccine COVID Testing Landscape: A Virtual Roundtable Discussion

Sponsored by
Thermo Fisher Scientific

With COVID-19 vaccines rolling out, clinical labs and test developers are preparing for changes in both demand for testing and types of testing for SARS-CoV-2.

May
10
Featured Webinar

Predicting COVID-19 Severity: Leveraging the Host Immune Response to Identify High-Risk Patients and Improve Outcomes

Sponsored by
MeMed

Amid the COVID-19 pandemic, hospitals and intensive care units around the world have been overwhelmed by unprecedented levels of demand. 

May
13
Featured Webinar

Limits of Detection Matter: New Challenges for SARS-CoV-2 Diagnostics and COVID-19 Patient Management

Sponsored by
LGC SeraCare Life Sciences

As we pass the one-year anniversary of both the COVID-19 pandemic and the first Emergency Use Authorized SARS-CoV-2 PCR detection assays, there remains significant opportunity for clinical laboratories to advance testing and support improved patient management.

May
18
Featured Webinar

Put Your Money Where Your Mouth Is: Tracking and Attacking COVID-19 through State-Wide Saliva Surveillance

Sponsored by
Bio-Rad

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.  

What's Popular?

In Infectious Disease

  1. CLIA Waiver in Hand, Binx Health Targeting Retailers, Urgent Care Centers With STI Tests

    Premium

  2. Hologic to Acquire Finnish MDx Firm Mobidiag for Approximately $795M

  3. Novacyt in Dispute with UK Department of Health and Social Care Over Coronavirus Test Contract

  4. BioMérieux Gets CE Mark for Three Dengue Immunoassays

  5. FDA Issues First EUA for COVID-19 Antibody Test Using Self-Collected Blood Samples

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.